Rohit Kohli

Affiliations: 
CCHMC, Cincinnati, United States 
Area:
Obesity, Fatty Liver Disease
Google:
"Rohit Kohli"
Mean distance: 16.05 (cluster 7)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Babu Balagopal P, Kohli R, Uppal V, et al. (2024) Effect of N-acetyl cysteine in children with metabolic dysfunction-associated steatotic liver disease-A pilot study. Journal of Pediatric Gastroenterology and Nutrition
Schenker RB, Machle CJ, Schmidt KA, et al. (2024) Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity. Liver International : Official Journal of the International Association For the Study of the Liver
Bozadjieva-Kramer N, Shin JH, Li Z, et al. (2024) Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance. Jci Insight. 9
Jones RB, Arenaza L, Rios C, et al. (2021) Genotype, Arachidonic Acid Intake, and Unsaturated Fat Intake Influences Liver Fibrosis in Hispanic Youth with Obesity. Nutrients. 13
Bhattacharjee J, Borra VJ, Salem ESB, et al. (2021) Hepatic Ago2 Regulates PPARα for Oxidative Metabolism Linked to Glycemic Control in Obesity and Post Bariatric Surgery. Endocrinology. 162
Myronovych A, Bhattacharjee J, Salazar-Gonzalez RM, et al. (2020) Assessment of the role of FGF15 in mediating the metabolic outcomes of murine Vertical Sleeve Gastrectomy (VSG). American Journal of Physiology. Gastrointestinal and Liver Physiology
Lin CH, Kohli R. (2020) Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. Current Gastroenterology Reports. 22: 52
Xi D, Bhattacharjee J, Salazar-Gonzalez RM, et al. (2020) Rebaudioside affords hepatoprotection ameliorating sugar sweetened beverage- induced nonalcoholic steatohepatitis. Scientific Reports. 10: 6689
Kumar S, Verma AK, Rani R, et al. (2020) Hepatic deficiency of augmenter of liver regeneration predisposes to nonalcoholic steatohepatitis and fibrosis. Hepatology (Baltimore, Md.)
Kumar S, Rani R, Verma AK, et al. (2020) Deficiency of Augmenter of Liver Regeneration is Critical Predisposing Factor for Nonalcoholic Steatohepatitis and Fibrosis The Faseb Journal. 34: 1-1
See more...